James Chih-Hsin Yang
MD, PhD
Director, Department of Oncology
👥Biography 个人简介
James Yang is one of the foremost global authorities on EGFR-mutant lung cancer and has expanded the therapeutic landscape for exon 20 insertions. His multi-national trial leadership has been pivotal in regulatory approvals for amivantamab and other agents. He has authored over 500 publications in thoracic oncology.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 James Chih-Hsin Yang 的研究动态
Follow James Chih-Hsin Yang's research updates
留下邮箱，当我们发布与 James Chih-Hsin Yang（National Taiwan University Hospital）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment